NYQ·Healthcare·$428M·#69 / 520 in Healthcare
CTEV Claritev Corporation
69SOLID
CATEGORY BREAKDOWN
GROWTH6
QUALITY71
STABILITY100
VALUATION100
GOVERNANCE67
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+3.7%
6
> 50% strong
Gross Margin
Revenue retained after direct costs
67.2%
96
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
-2654.4%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.4x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
8
33
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
7.0%
50
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-1.2%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE CTEV WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when CTEV's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.